Interleukin-10 as a potential regulator of hepcidin homeostasis in overweight and obese children: A cross-sectional study in Taiwan

Nutrition

Volumn 30, Issue 10, 2014, Pages 1165-1170

  Chang, Jung Su ^a   Li, Yu Ling ^a   Lu, Chiou Han ^a   Owaga, Eddy ^a   Chen, Wei Yu ^a,b   Chiou, Hung Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepcidin; IL 10; Iron deficiency; Obese children; Taiwan

Indexed keywords

FERRITIN; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; IRON; NITRIC OXIDE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BODY FAT; BODY MASS; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FERRITIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEPLETION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OBESITY; PHASE TRANSITION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TAIWAN; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPLICATION; DEFICIENCY; IRON OVERLOAD; SEX DIFFERENCE;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPCIDINS; HOMEOSTASIS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; IRON; IRON OVERLOAD; MALE; NITRIC OXIDE; NUTRITIONAL STATUS; OBESITY; OVERWEIGHT; PREVALENCE; SEX FACTORS; TAIWAN;

EID: 84908143993     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.02.021     Document Type: Article

References (26)

1. Pan W.H., Lee M.S., Chuang S.Y., Lin Y.C., Fu M.L. Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev 2008, 9(Suppl 1):22-31.
2. Cepeda-Lopez A.C., Osendarp S.J., Melse-Boonstra A., Aeberli I., Gonzalez-Salazar F., Feskens E., et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 2011, 93:975-983.
3. del Giudice E.M., Santoro N., Amato A., Brienza C., Calabro P., Wiegerinck E.T., et al. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009, 94:5102-5107.
4. Nead K.G., Halterman J.S., Kaczorowski J.M., Auinger P., Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004, 114:104-108.
5. Shaw N.S. Iron deficiency and anemia in school children and adolescents. J Formos Med Assoc 1996, 95:692-698.
6. Wang L SN. Iron status in the Taiwanese children aged 6-12 years old. In Available at: . Accessed January 15 2014. https://consumerfdagovtw/Pages/Listaspx?nodeID=2862003.
7. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
8. Lee P., Peng H., Gelbart T., Beutler E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 2004, 101:9263-9265.
9. Arslan N., Erdur B., Aydin A. Hormones and cytokines in childhood obesity. Indian Pediatr 2010, 47:829-839.
10. Choi S.O., Cho Y.S., Kim H.L., Park J.W. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun 2007, 356:312-317.
11. Pinto J.P., Ribeiro S., Pontes H., Thowfeequ S., Tosh D., Carvalho F., et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 2008, 111:5727-5733.
12. Sanad M., Osman M., Gharib A. Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr 2011, 37:34.
13. Miura K., Taura K., Kodama Y., Schnabl B., Brenner D.A. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008, 48:1420-1429.
14. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011, 117:4425-4433.
15. Chang J.S., Chang C.C., Chien E.Y., Lin S.S., Cheng-Shiuan T., Bai C.H., et al. Association between interleukin 1beta and Interleukin-10 concentrations: a cross-sectional study in young adolescents in Taiwan. BMC Pediatr 2013, 13:123.
16. Exceutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
17. Tan C.E., Ma S., Wai D., Chew S.K., Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 2004, 27:1182-1186.
18. Looker A.C., Dallman P.R., Carroll M.D., Gunter E.W., Johnson C.L. Prevalence of iron deficiency in the United States. JAMA 1997, 277:973-976.
19. Chang J.S., Lin S.M., Chao J.C., Chen Y.C., Wang C.M., Chou N.H., et al. Serum ferritin contributes to racial or geographic disparities in metabolic syndrome in Taiwan. Public Health Nutr 2014, 17:1498-1506.
20. Chang J.S., Lin S.M., Huang T.C., Chao J.C., Chen Y.C., Pan W.H., et al. Serum ferritin and risk of the metabolic syndrome: a population-based study. Asia Pac J Clin Nutr 2013, 22:400-407.
21. Cook J.D., Finch C.A., Smith N.J. Evaluation of the iron status of a population. Blood 1976, 48:449-455.
22. Aeberli I., Hurrell R.F., Zimmermann M.B. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes (Lond) 2009, 33:1111-1117.
23. Kemna E.H., Kartikasari A.E., van Tits L.J., Pickkers P., Tjalsma H., Swinkels D.W. Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis 2008, 40:339-346.
24. Goodnough J.B., Ramos E., Nemeth E., Ganz T. Inhibition of hepcidin transcription by growth factors. Hepatology 2012, 56:291-299.
25. Troutt J.S., Rudling M., Persson L., Stahle L., Angelin B., Butterfield A.M., et al. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clin Chem 2012, 58:1225-1232.
26. Gardenghi S., Grady R.W., Rivella S. Anemia, ineffective erythropoiesis, andhepcidin: interacting factors in abnormal iron metabolism leading toiron overload in beta-thalassemia. Hematol Oncol Clin North Am 2010, 24:1089-1107.